Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Discovery and Development of Natural Products for Cancer Interception and Prevention RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed) UH3, UG3 Clinical Trial Not Allowed 06/14/2025 Altaf Mohammed, Ph.D.
Understanding Chronic Conditions Understudied Among Women RFA-OD-23-013 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 06/21/2024 Goli Samimi, Ph.D., M.P.H.
Understanding Chronic Conditions Understudied Among Women RFA-OD-23-014 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 06/21/2024 Goli Samimi, Ph.D., M.P.H.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-028 (RM1 Clinical Trial Optional) RM1 Clinical Trial Optional 06/10/2025 Rachel Altshuler, Ph.D.
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention NOT-CA-21-121 09/08/2024 Sharon Ross, Ph.D., M.P.H.
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer PAR-22-061 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/08/2025 Young Kim, Ph.D.
Cancer Immunoprevention Network (CIP-Net) Research Projects RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed) UH3, UG3 07/04/2024 Altaf Mohammed, Ph.D.
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials NOT-CA-23-071 07/01/2025 Ellen Richmond, M.S., G.N.P.-B.C.
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional) R01 Clinical Trial Optional 02/07/2025 Rachel Altshuler, Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-279 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2027 Edward Sauter, M.D., Ph.D.